Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
25.34
+0.86 (3.51%)
At close: May 29, 2026, 4:00 PM EDT
25.98
+0.64 (2.53%)
After-hours: May 29, 2026, 7:09 PM EDT
Arcus Biosciences Employees
Arcus Biosciences had 601 employees as of December 31, 2025. The number of employees decreased by 26 or -4.15% compared to the previous year.
Employees
601
Change (1Y)
-26
Growth (1Y)
-4.15%
Revenue / Employee
$392,679
Profits / Employee
-$613,977
Market Cap
3.19B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 601 | -26 | -4.15% |
| Dec 31, 2024 | 627 | 50 | 8.67% |
| Dec 31, 2023 | 577 | 77 | 15.40% |
| Dec 31, 2022 | 500 | 134 | 36.61% |
| Dec 31, 2021 | 366 | 130 | 55.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Telix Pharmaceuticals | 1,184 |
| Beam Therapeutics | 522 |
| Denali Therapeutics | 507 |
| Arcutis Biotherapeutics | 354 |
| Dyne Therapeutics | 263 |
| Alumis | 227 |
| Structure Therapeutics | 220 |
| Relay Therapeutics | 193 |
RCUS News
- 3 days ago - Arcus Biosciences to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference - Business Wire
- 12 days ago - Arcus Biosciences assumed with a Buy at Truist - TheFly
- 19 days ago - Arcus Biosciences price target raised to $22 from $20 at Morgan Stanley - TheFly
- 24 days ago - Arcus Biosciences Earnings Call Transcript: Q1 2026 - Transcripts
- 24 days ago - Arcus Biosciences Slides: Q1 2026 - Filings
- 24 days ago - Arcus Biosciences Earnings release: Q1 2026 - Filings
- 24 days ago - Arcus Biosciences Quarterly report: Q1 2026 - Filings
- 24 days ago - Arcus Biosciences Reports First-Quarter 2026 Financial Results and Provides a Pipeline Update - Business Wire